CSPC Pharmaceutical Group Limited — Earnings Release 2000

Sep 20, 2000

Listed Company Information

CHINA PHARMA<1093> - Results Announcement China Pharmaceutical Enterprise and Investment Corporation Ltd announced on 20/9/2000: (stock codes: Ord: 1093 & War: 837) Year end date: 31/12/2000 Currency: HKD (Unaudited) (Unaudited) Last Current Corresponding Period Period from 1/1/2000 from 1/1/1999 to 30/6/2000 to 30/6/1999 Turnover : 494,195,000 356,562,000 Profit/(Loss) from Operations : 93,371,000 85,305,000 Finance cost : (15,799,000) (14,700,000) Share of Profit/(Loss) of Associates : - - Share of Profit/(Loss) of Jointly Controlled Entities : 3,171,000 2,436,000 Profit/(Loss) after Tax & MI : 70,630,000 70,399,000 % Change over Last Period : +0.3% EPS/(LPS)-Basic : 5.69 cents 6.73 cents -Diluted : 5.62 cents 6.70 cents Extraordinary (ETD) Gain/(Loss) : - - Profit/(Loss) after ETD Items : 70,630,000 70,399,000 Interim Dividend per Share : NIL NIL (Specify if with other options) : - - B/C Dates for Interim Dividend : N/A Payable Date : N/A B/C Dates for (-) General Meeting : N/A Other Distribution for Current Period : - B/C Dates for Other Distribution : N/A Remarks: (1) Earnings per share The calculation of the basic and diluted earnings per share is based on the following data: Six month ended June 30 2000 1999 Profit attributable to shareholders HK$70,630,000 HK$70,399,000 ============= ============= Weighted average number of ordinary shares for the purposes of basic earnings per share 1,240,411,126 1,045,950,006 Effect of dilutive potential ordinary shares in respect of share options 15,295,455 5,544,554 ------------- -------------- Weighted average number of ordinary shares for the purposes of diluted earnings per share 1,255,706,581 1,051,494,560 ============= ============= The computation of diluted earnings per share for the six months ended June 30, 2000 does not assume the exercise of the Company's outstanding warrants as the exercise price is higher than the fair value per share during the period. (2) Adoption of statement of standard accounting practice ("SSAP") Certain comparative figures have been reclassified to conform with the current presentation as required under SSAP 1 (Revised) "Presentation of financial statements" issued by the Hong Kong Society of Accountants.